Sun Pharma

Sun Pharma Acquires Three Anti-Inflammation Brands From Aksigen

Sun Pharma Acquires Three Anti-Inflammation Brands From Aksigen

BY Press Trust of India

Sun Pharma To Acquire Concert Pharmaceuticals In $576 Million Deal

Sun Pharma To Acquire Concert Pharmaceuticals In $576 Million Deal

BY Press Trust of India

USFDA Pulls Up Sun Pharma For Lapses In Halol Plant

USFDA Pulls Up Sun Pharma For Lapses In Halol Plant

BY Press Trust of India

Pharma sector

Dr Reddy's, Sun Pharma Recall Products In US For Manufacturing Issues

BY Press Trust of India

Sun Pharma Inks Licensing Pact With SPARC To Commercialise Medication in US Market

Sun Pharma Inks Licensing Pact With SPARC To Commercialise Medication in US Market

BY Press Trust of India

Sun Pharma Q1 Profit Up 43% At Rs 2,061 Crore

Sun Pharma Q1 Profit Up 43% At Rs 2,061 Crore

BY Press Trust of India

Sun Pharma, Glenmark Recall Products In US Due To Manufacturing Issues

Sun Pharma, Glenmark Recall Products In US Due To Manufacturing Issues

BY Press Trust of India

Advertisement

Stock Market Today: Sensex Falls Over 1,200 Points, Nifty Below 16,000

Stock Market Today: Sensex Falls Over 1,200 Points, Nifty Below 16,000

BY Outlook Business Team

Pharma sector

Sun Pharma Shares Drop Over 4% After Reporting Loss In March Quarter

BY Press Trust of India

Stock Market Today: Sensex Slips Over 300 Points, Nifty Below 16,600

Stock Market Today: Sensex Slips Over 300 Points, Nifty Below 16,600

BY Outlook Business Team

Sensex Slips 106 Points At 54,364, Nifty Ends At 16,240 Dragged By Tata Steel, Sun Pharma, NTPC

Sensex Slips 106 Points At 54,364, Nifty Ends At 16,240 Dragged By Tata Steel, Sun Pharma, NTPC

BY PTI

Sun Pharma Gets Form 483 From USFDA For Regulatory Violations At Halol Plant

Sun Pharma Gets Form 483 From USFDA For Regulatory Violations At Halol Plant

BY PTI

Sensex, Nifty Erase Intraday Gains, End on A Subdued Note; Reliance Falls A Day Ahead Of Earnings

Sensex, Nifty Erase Intraday Gains, End on A Subdued Note; Reliance Falls A Day Ahead Of Earnings

BY Outlook Business Team

Aurobindo, Sun Pharma Recall Products In US Market

Aurobindo, Sun Pharma Recall Products In US Market

BY PTI

Advertisement

Total revenue from operations rose to Rs 9,863 crore in the third quarter.

Sun Pharma Net Profit Up 11% At Rs 2,059 Crore In December Quarter

BY PTI

US is the worlds largest market of medicines

Sun Pharma, Lupin Recall Products In US market

BY PTI